S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
Log in
NASDAQ:OFIX

Orthofix Medical Stock Forecast, Price & News

$28.99
-0.86 (-2.88 %)
(As of 09/21/2020 02:15 PM ET)
Add
Compare
Today's Range
$28.91
Now: $28.99
$29.16
50-Day Range
$28.24
MA: $31.08
$34.98
52-Week Range
$22.11
Now: $28.99
$54.90
Volume2,273 shs
Average Volume141,862 shs
Market Capitalization$560.32 million
P/E RatioN/A
Dividend YieldN/A
Beta1.04
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Read More
Orthofix Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone214-937-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$459.95 million
Cash Flow$2.99 per share
Book Value$17.22 per share

Profitability

Net Income$-28,460,000.00

Miscellaneous

Employees1,055
Market Cap$560.32 million
Next Earnings Date10/26/2020 (Estimated)
OptionableOptionable
$28.99
-0.86 (-2.88 %)
(As of 09/21/2020 02:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

How has Orthofix Medical's stock been impacted by COVID-19?

Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, OFIX shares have decreased by 5.5% and is now trading at $28.99.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Orthofix Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Orthofix Medical
.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, October 26th 2020.
View our earnings forecast for Orthofix Medical
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc (NASDAQ:OFIX) posted its earnings results on Thursday, August, 6th. The medical device company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.80) by $0.21. The medical device company had revenue of $73.14 million for the quarter, compared to the consensus estimate of $53.80 million. Orthofix Medical had a positive return on equity of 2.47% and a negative net margin of 5.22%.
View Orthofix Medical's earnings history
.

What price target have analysts set for OFIX?

2 analysts have issued twelve-month price targets for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they expect Orthofix Medical's stock price to reach $49.00 in the next year. This suggests a possible upside of 69.0% from the stock's current price.
View analysts' price targets for Orthofix Medical
.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 251,400 shares, a drop of 14.3% from the August 15th total of 293,500 shares. Based on an average daily trading volume, of 114,900 shares, the days-to-cover ratio is presently 2.2 days. Approximately 1.4% of the shares of the stock are sold short.
View Orthofix Medical's Short Interest
.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Gilead Sciences (GILD), Exxon Mobil (XOM), Biogen (BIIB), Edwards Lifesciences (EW), Zoetis (ZTS), ABIOMED (ABMD), Allergan (AGN) and Alphabet (GOOG).

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the following people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
  • Mr. Davide Bianchi, Pres of Global Extremities (Age 54)

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.21%), Paradice Investment Management LLC (5.32%), Nuveen Asset Management LLC (2.70%), Gabelli Funds LLC (1.38%), Bank of Montreal Can (1.29%) and Bank of New York Mellon Corp (1.18%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria.
View institutional ownership trends for Orthofix Medical
.

Which institutional investors are selling Orthofix Medical stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Jacobs Levy Equity Management Inc., SG Americas Securities LLC, Paradice Investment Management LLC, Vanguard Group Inc., Man Group plc, Goldman Sachs Group Inc., and Engineers Gate Manager LP.
View insider buying and selling activity for Orthofix Medical
.

Which institutional investors are buying Orthofix Medical stock?

OFIX stock was bought by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Nuveen Asset Management LLC, Assenagon Asset Management S.A., Mackay Shields LLC, Canada Pension Plan Investment Board, Bank of Montreal Can, Bank of New York Mellon Corp, and Federated Hermes Inc.. Company insiders that have bought Orthofix Medical stock in the last two years include James F Hinrichs, Jon Carl Serbousek, and Ronald A Matricaria.
View insider buying and selling activity for Orthofix Medical
.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $28.99.

How big of a company is Orthofix Medical?

Orthofix Medical has a market capitalization of $560.32 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is www.orthofix.com.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.